Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1085831


Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015


Description: Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Republic of Korea drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Republic of Korea

Scope

- The report provides information on the drug delivery devices market in Republic of Korea.
- Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors such as AstraZeneca International plc, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, and Baxter International Inc.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the drug delivery devices market in Republic of Korea.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Drug delivery devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry powder inhaler
3.3 Infusion Systems
3.3.1 Infusion pumps
3.3.2 Syringe pumps
3.3.3 Disposable Infusion sets
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Premarket Notification for Class I Devices
5.1.3 Pre-market Approval for Class II, III and IV Devices
5.1.3.1 Technical Review:
5.1.3.2 Type Testing:
5.1.3.3 Applying for Product License:
5.1.3.4 KGMP Certification
5.1.4 License Fee
5.1.5 License Application Processing Duration
5.2 Post-market Surveillance
6 Pricing and Reimbursement
7 Distribution Structure
7.1 Distribution Structure
8 Drug Delivery Devices In Republic of Korea
8.1 Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, Republic of Korea, Company Share (2007-2008)
9 Infusion Systems In Republic of Korea
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, Republic of Korea, Company Share (2007-2008)
10 Inhalation Systems In Republic of Korea
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, Republic of Korea, Company Share (2007-2008)
11 Overview of Key Companies in Republic of Korea Drug Delivery Devices Market
11.1 AstraZeneca PLC
11.1.1 Company Overview
11.2 Boehringer Ingelheim GmbH
11.2.1 Company Overview
11.3 Baxter International Inc.
11.3.1 Company Overview
11.4 Novartis AG
11.4.1 Company Overview
11.5 Terumo Corporation
11.5.1 Company Overview
11.5.2 Terumo Corporation Pipeline Products
11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type
11.5.2.2 Terumo Corporation Pipeline Products By Development Stage
11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area
11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials
11.5.2.5 Terumo Corporation Pipeline Products By News Summary
11.6 Cardinal Health, Inc.
11.6.1 Company Overview
11.7 GlaxoSmithKline plc
11.7.1 Company Overview
11.8 B. Braun Melsungen AG
11.8.1 Company Overview
11.9 Smiths Medical
11.9.1 Company Overview
11.10 Fresenius Kabi AG
11.10.1 Company Overview
11.11 Consort Medical plc
11.11.1 Company Overview
11.11.2 Consort Medical plc Pipeline Products
11.11.2.1 Bespak plc Pipeline Products By Equipment Type
11.11.2.2 Bespak plc Pipeline Products By Development Stage
11.11.2.3 Bespak plc Pipeline Products By Therapy Area
11.12 Shin Chang Medical Co., Ltd.
11.12.1 Company Overview
11.13 Woo Young Medical Co., Ltd.
11.13.1 Company Overview
11.14 Hospira, Inc.
12 Financial Deals Landscape
12.1 Partnerships
12.1.1 BioChemics Signs an Agreement With Pacific Pharmaceutical
12.1.2 Novartis Terminates Its Licensing Agreement With NexMed
12.1.3 Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals
12.1.4 Teikoku Pharma Enters Into An Agreement With Eisai
13 Appendix
13.1 Global Markets Direct Research Methodology
13.2 Secondary Research
13.3 Primary Research
13.4 Models
13.5 Forecasts
13.6 Expert Panel Validation
13.7 Currency Conversion
13.8 Contact Us
13.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Total Healthcare Expenditure, Republic of Korea, 2000 - 2007 13
Table 2: Hospital Wards by Specialty in Republic of Korea, 2003-2007 17
Table 3: Doctors by Specialty in Republic of Korea, 2003-2007 18
Table 4: Healthcare Institutions in Republic of Korea, 2001-2005 19
Table 5: Healthcare Personnel in Republic of Korea, 1975-2002 19
Table 6: Classification of Medical Equipment in Republic of Korea 21
Table 7: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015 29
Table 8: Drug Delivery Devices, Republic of Korea, Cross-Category Analysis, 2000-2015 30
Table 9: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Historic, 2000-2008 31
Table 10: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Forecast, 2008-2015 32
Table 11: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2015 33
Table 12: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2008 34
Table 13: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2008-2015 35
Table 14: Drug Delivery Devices, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008 36
Table 15: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008 37
Table 16: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015 38
Table 17: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008 39
Table 18: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2008-2015 39
Table 19: Infusion Systems, Republic of Korea, Average Price ($), Historic, 2000-2008 40
Table 20: Infusion Systems, Republic of Korea, Average Price ($), Forecast, 2008-2015 40
Table 21: Infusion Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2007-2008 41
Table 22: Infusion Systems, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008 42
Table 23: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008 43
Table 24: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015 44
Table 25: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008 45
Table 26: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2008-2015 46
Table 27: Inhalation Systems, Republic of Korea, Average Price ($), Historic, 2000-2008 47
Table 28: Inhalation Systems, Republic of Korea, Average Price ($), Forecast, 2008-2015 47
Table 29: Inhalation Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2007-2008 48
Table 30: Inhalation Systems, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008 49
Table 31: Terumo Corporation Pipeline Products by Equipment Type 52
Table 32: Terumo Corporation Pipeline Products By Development Stage 52
Table 33: Terumo Corporation Pipeline Products By Therapy Area 53
Table 34: Terumo Corporation Pipeline Products By Clinical Trials 53
Table 35: Terumo Corporation Pipeline Products By News Summary 54
Table 36: Bespak plc Pipeline Products by Equipment Type 59
Table 37: Bespak plc Pipeline Products By Development Stage 59
Table 38: Bespak plc Pipeline Products By Therapy Area 60
Table 39: BioChemics Signs An Agreement With Pacific Pharmaceutical 62
Table 40: Novartis Terminates Its Licensing Agreement With NexMed 63
Table 41: Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals 64
Table 42: Teikoku Pharma Enters Into An Agreement With Eisai 65
Table 43: USD to Local Currency, Average Exchange Rate 2008 69


Companies Mentioned AstraZeneca PLC Boehringer Ingelheim GmbH Baxter International Inc. Novartis AG Terumo Corporation Cardinal Health, Inc. GlaxoSmithKline plc B. Braun Melsungen AG Smiths Medical Fresenius Kabi AG Consort Medical plc Shin Chang Medical Co., Ltd. Woo Young Medical Co., Ltd. Hospira, Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1085831

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 08:04:58
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/1085831
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,886.00
Electronic (PDF) - Site License €3,772.00
Electronic (PDF) - Enterprisewide €5,659.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 08:04:58

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)